Becton, Dickinson and Company
LSE: 0R19.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Thomas E. Polen Jr.
- Employees
- 70,000
- Headquarters
- Franklin Lakes, United States
- IPO year
- 2014
- Market cap
- $41.8B
- Website
- https://www.bd.com
Loading 0R19…
Loading profile data…Frequently asked questions about 0R19
What does Becton, Dickinson and Company (0R19.L) do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
Where does 0R19.L trade?
Becton, Dickinson and Company (0R19.L) trades on the London Stock Exchange.
What sector is 0R19.L in?
Becton, Dickinson and Company (0R19.L) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Becton, Dickinson and Company?
Thomas E. Polen Jr. is the chief executive officer of Becton, Dickinson and Company (0R19.L).
Where is Becton, Dickinson and Company headquartered?
Becton, Dickinson and Company is headquartered in United States.
Does 0R19.L pay a dividend?
Yes — Becton, Dickinson and Company (0R19.L) paid a trailing twelve-month dividend of USD 49.54 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0R19.L go public?
Becton, Dickinson and Company (0R19.L) completed its initial public offering in 2014.